Late chest wall toxicity after MammoSite® breast brachytherapy
- 1 January 2009
- journal article
- Published by Elsevier in Brachytherapy
- Vol. 8 (1) , 19-25
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Technology Insight: MammoSite®—a new device for delivering brachytherapy following breast-conserving therapyNature Clinical Practice Oncology, 2007
- Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical studyThe American Journal of Surgery, 2006
- Clinical experience with the MammoSite® radiation therapy system for brachytherapy of breast cancer: Results from an international phase II trialRadiotherapy and Oncology, 2006
- Initial Outcomes for Patients Treated on the American Society of Breast Surgeons MammoSite Clinical Trial for Ductal Carcinoma-In-Situ of the BreastAnnals of Surgical Oncology, 2006
- Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: Toxicity analysis of RTOG 95-17International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Initial dosimetric experience using simple three-dimensional conformal external-beam accelerated partial-breast irradiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Acute complications of MammoSite brachytherapy: A single institution's initial clinical experienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Chest wall dose in MammoSite™ breast brachytherapy: Radiobiologic estimations of late complication risk based on dose–volume considerationsBrachytherapy, 2005
- Mandibular OsteoradionecrosisJournal of Clinical Oncology, 2004
- Long-term outcome following breast-conserving surgery and radiation therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995